Taxa de gestação em cabras Alpinas e Saanen tratadas com hCG no terceiro dia após o estro Pregnancy rate and progesterone concentration of Alpine and Saanen goats treated with hCG the third day after estrus

Avaliou-se o efeito da aplicação da gonadotrofina coriônica humana (hCG) sobre a taxa e duração da gestação e sobre a concentração plasmática de progesterona (P4) em cabras lactantes das raças Alpina (83) e Saanen (60), na estação de acasalamento induzida pelo programa de fotoperíodo artificial. Os animais foram distribuídos em dois tratamentos após a cobrição; as cabras do tratamento 1 (T1 controle) receberam solução salina via intramuscular (1ml), e as do tratamento 2 (T2) receberam 250UI do hCG, no terceiro dia no pós-estro. As taxas de gestação, detectadas por exame ultra-sonográfico, realizado no 35º após a cobrição, para as cabras das raças Alpina e Saanen controle e tratadas, foram de 80,4; 70,3; 72,7; 81,5%, respectivamente, não diferindo entre os tratamentos e entre as raças (P>0,05). A taxa média de gestação foi 77,2 e 75,0% para os animais controle e tratados, respectivamente. A duração da gestação não foi influenciada pelos tratamentos (P>0,05). As amostras de sangue para análise da concentração plasmática de progesterona (P4) foram coletadas de cinco cabras Alpina por tratamento, no dia do estro (dia 0) e aos 3, 8, 15, 21, 42 e 60 dias após o estro. Não houve diferença na concentração plasmática média de P4 entre os tratamentos (P>0,05), sendo de 5,84ng/ml para T1 e 5,76ng/ml para T2. Observou-se diferença em relação aos dias de coleta (PThe experimental objective was to evaluate the effect of human chorionic gonadotropin (hCG) administration on pregnancy rate and gestation length and on serum concentration of progesterone (P4) in Alpine (83) and Saanen (60) dairy goats induced by artificial photoperiod to enter the breeding season. Animals were randomly allocated to two treatments following estrus: in treatment 1 (T1) goats received 1ml saline solution and in treatment 2 (T2) animals received 250IU of hCG in 1ml saline intramuscularly during the third day after estrus. Pregnancy rates detected by ultrasound technology 35 days after mating did not differ significantly between treatments (P>0.05). They equaled 80.4 and 70.3% for Alpine goats and 72.7 and 81.5% for Saanen goats in T1 and T2, respectively. Overall pregnancy rates were 77.2% and 75.0% for the controls and treated animals, respectively. Gestation length was not affected by the hCG treatment. Blood samples were collected from 5 Alpine does from each treatment the day of estrus (day 0) and on days 3, 8, 15, 21, 42 and 60 after estrus, for determination of progesterone concentration in plasma. Means were 5.84 and 5.76ng/ml for the control and treated does, respectively, and were not affected by treatment (P>0.05), although concentrations did differ among collection days (P<0.05). The administration of hCG the third day after estrus did not affect pregnancy rate or P4 concentration and had no beneficial effect on reproduction in the does

Indução da ovulação em cabras, fora da estação reprodutiva, com LH e GnRH e com estro induzido por progestágenos Induction of the out-of-season ovulation (with LH and GnRH) and estrus (with progesterone) in goats

Quarenta e cinco cabras foram sincronizadas com o uso de esponjas intravaginais impregnadas com 60mg de acetato de medroxiprogesterona (MAP) por nove dias, associadas com 200UI de gonadotrofina coriônica equina (eCG) e 37,5&micro;g de cloprostenol no sétimo dia. Os animais foram separados em três grupos e receberam, 24 horas após a retirada das esponjas, solução salina ou hormônios, no seguinte esquema: T1 (controle) - 1ml de solução salina; T2 - 5mg de hormônio luteinizante (LH) e T3 - 12,5&micro;g do hormônio liberador de gonadotrofina (GnRH). Houve diferença (P0,05) quanto ao intervalo da retirada da esponja ao aparecimento do estro, que foi, em média, 34,8, 29,3 e 31,5 horas, respectivamente. O intervalo médio da retirada da esponja à ovulação foi de 46,6, 52,1 e 41,6 horas, respectivamente, com diferença significativa entre T2 e T3 (P0,05). A aplicação de LH e do GnRH para induzir e sincronizar a ovulação em cabras fora da estação reprodutiva não apresentou resultados satisfatórios.In order to achieve estrous synchronization, intravaginal sponges impregnated with 60mg of medroxyprogesterone acetate (MPA) were implanted in 45 goats for nine days. On day 7, 200IU of equine chorionic gonadotropin (eCG) and 37.5&micro;g of cloprostenol were administered to each doe. The animals were randomly allocated in three treatments with 15 animals each. Twenty four hours after intravaginal sponge removal, does were administered 1ml saline solution (control T1), 5mg LH (T2) and 2.5&micro;g GnRH (T3) intramuscular injection. Percentages of animals in estrus were 100.0; 73.3 and 66.6 (P<0.05) and average intervals from sponge removal to start of estrus were 34.8, 29.3 and 31.5 hours for T1, T2 and T3, respectively, being those differences not statistically significant. The average intervals from sponge removal to ovulation were 46.6, 52.1 and 41.6 hours for T1, T2 and T3, respectively, with the difference between T2 and T3 being statistically significant (P<0.01). Ovulation time averages were 21.3, 26.8 and 22.3 hours after injections for T1, T2 and T3 , respectively

Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery

Background: Ileus is common after elective colorectal surgery, and is associated with increased adverse events and prolonged hospital stay. The aim was to assess the role of non-steroidal anti-inflammatory drugs (NSAIDs) for reducing ileus after surgery. Methods: A prospective multicentre cohort study was delivered by an international, student- and trainee-led collaborative group. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The primary outcome was time to gastrointestinal recovery, measured using a composite measure of bowel function and tolerance to oral intake. The impact of NSAIDs was explored using Cox regression analyses, including the results of a centre-specific survey of compliance to enhanced recovery principles. Secondary safety outcomes included anastomotic leak rate and acute kidney injury. Results: A total of 4164 patients were included, with a median age of 68 (i.q.r. 57\u201375) years (54\ub79 per cent men). Some 1153 (27\ub77 per cent) received NSAIDs on postoperative days 1\u20133, of whom 1061 (92\ub70 per cent) received non-selective cyclo-oxygenase inhibitors. After adjustment for baseline differences, the mean time to gastrointestinal recovery did not differ significantly between patients who received NSAIDs and those who did not (4\ub76 versus 4\ub78 days; hazard ratio 1\ub704, 95 per cent c.i. 0\ub796 to 1\ub712; P = 0\ub7360). There were no significant differences in anastomotic leak rate (5\ub74 versus 4\ub76 per cent; P = 0\ub7349) or acute kidney injury (14\ub73 versus 13\ub78 per cent; P = 0\ub7666) between the groups. Significantly fewer patients receiving NSAIDs required strong opioid analgesia (35\ub73 versus 56\ub77 per cent; P &lt; 0\ub7001). Conclusion: NSAIDs did not reduce the time for gastrointestinal recovery after colorectal surgery, but they were safe and associated with reduced postoperative opioid requirement

Safety of hospital discharge before return of bowel function after elective colorectal surgery

© 2020 BJS Society Ltd Published by John Wiley & Sons LtdBackground: Ileus is common after colorectal surgery and is associated with an increased risk of postoperative complications. Identifying features of normal bowel recovery and the appropriateness for hospital discharge is challenging. This study explored the safety of hospital discharge before the return of bowel function. Methods: A prospective, multicentre cohort study was undertaken across an international collaborative network. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The main outcome of interest was readmission to hospital within 30 days of surgery. The impact of discharge timing according to the return of bowel function was explored using multivariable regression analysis. Other outcomes were postoperative complications within 30 days of surgery, measured using the Clavien–Dindo classification system. Results: A total of 3288 patients were included in the analysis, of whom 301 (9·2 per cent) were discharged before the return of bowel function. The median duration of hospital stay for patients discharged before and after return of bowel function was 5 (i.q.r. 4–7) and 7 (6–8) days respectively (P < 0·001). There were no significant differences in rates of readmission between these groups (6·6 versus 8·0 per cent; P = 0·499), and this remained the case after multivariable adjustment for baseline differences (odds ratio 0·90, 95 per cent c.i. 0·55 to 1·46; P = 0·659). Rates of postoperative complications were also similar in those discharged before versus after return of bowel function (minor: 34·7 versus 39·5 per cent; major 3·3 versus 3·4 per cent; P = 0·110). Conclusion: Discharge before return of bowel function after elective colorectal surgery appears to be safe in appropriately selected patients

Safety of hospital discharge before return of bowel function after elective colorectal surgery

Background: Ileus is common after colorectal surgery and is associated with an increased risk of postoperative complications. Identifying features of normal bowel recovery and the appropriateness for hospital discharge is challenging. This study explored the safety of hospital discharge before the return of bowel function. Methods: A prospective, multicentre cohort study was undertaken across an international collaborative network. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The main outcome of interest was readmission to hospital within 30 days of surgery. The impact of discharge timing according to the return of bowel function was explored using multivariable regression analysis. Other outcomes were postoperative complications within 30 days of surgery, measured using the Clavien\u2013Dindo classification system. Results: A total of 3288 patients were included in the analysis, of whom 301 (9\ub72 per cent) were discharged before the return of bowel function. The median duration of hospital stay for patients discharged before and after return of bowel function was 5 (i.q.r. 4\u20137) and 7 (6\u20138) days respectively (P &lt; 0\ub7001). There were no significant differences in rates of readmission between these groups (6\ub76 versus 8\ub70 per cent; P = 0\ub7499), and this remained the case after multivariable adjustment for baseline differences (odds ratio 0\ub790, 95 per cent c.i. 0\ub755 to 1\ub746; P = 0\ub7659). Rates of postoperative complications were also similar in those discharged before versus after return of bowel function (minor: 34\ub77 versus 39\ub75 per cent; major 3\ub73 versus 3\ub74 per cent; P = 0\ub7110). Conclusion: Discharge before return of bowel function after elective colorectal surgery appears to be safe in appropriately selected patients